Femasys Stock Performance
| FEMY Stock | USD 1.04 0.02 1.89% |
The firm shows a Beta (market volatility) of 1.32, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Femasys will likely underperform. At this point, Femasys has a negative expected return of -0.0048%. Please make sure to confirm Femasys' maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Femasys performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Femasys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Femasys is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
1 | Femasys to Exhibit at The Canadian Fertility and Andrology Societys 70th Annual Meeting | 09/05/2024 |
2 | Acquisition by Larsen Charles of 8500 shares of Femasys subject to Rule 16b-3 | 09/06/2024 |
3 | Femasys Inc. Receives U.S. FDA Clearance to Market FemChec, an Innovative Diagnostic Solution for Fallopian Tube Check | 09/09/2024 |
4 | Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed for over 1.3M in Spanish Market | 09/11/2024 |
5 | Acquisition by Uzialko Edward R of 8500 shares of Femasys at 0.57 subject to Rule 16b-3 | 09/25/2024 |
6 | Femasys to Exhibit at ASRM 2024 and Participate in the Congress KEEPR Education Program | 10/10/2024 |
7 | Femasys Announces Issued U.S. Patent Covering FemBlocDevice for Female Permanent Birth Control | 11/01/2024 |
8 | Femasys to Exhibit at the Annual AAGL 2024 Global Conference | 11/07/2024 |
9 | Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update | 11/12/2024 |
10 | Aljian Capital Management LLC Makes New 27,000 Investment in Femasys Inc. | 11/19/2024 |
11 | Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed Infertility Treatment | 11/26/2024 |
| Begin Period Cash Flow | 13 M |
Femasys |
Femasys Relative Risk vs. Return Landscape
If you would invest 109.00 in Femasys on August 31, 2024 and sell it today you would lose (5.00) from holding Femasys or give up 4.59% of portfolio value over 90 days. Femasys is currently does not generate positive expected returns and assumes 3.7579% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Femasys, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Femasys Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Femasys' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Femasys, and traders can use it to determine the average amount a Femasys' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0013
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FEMY |
Estimated Market Risk
| 3.76 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Femasys is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Femasys by adding Femasys to a well-diversified portfolio.
Femasys Fundamentals Growth
Femasys Stock prices reflect investors' perceptions of the future prospects and financial health of Femasys, and Femasys fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Femasys Stock performance.
| Return On Equity | -1.38 | ||||
| Return On Asset | -0.6 | ||||
| Operating Margin | (20.24) % | ||||
| Current Valuation | 23.44 M | ||||
| Shares Outstanding | 22.9 M | ||||
| Price To Earning | 4.67 X | ||||
| Price To Book | 3.99 X | ||||
| Price To Sales | 25.07 X | ||||
| Revenue | 1.07 M | ||||
| Gross Profit | 764.28 K | ||||
| EBITDA | (13.17 M) | ||||
| Net Income | (14.25 M) | ||||
| Cash And Equivalents | 19.12 M | ||||
| Cash Per Share | 1.62 X | ||||
| Total Debt | 6.7 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 10.90 X | ||||
| Book Value Per Share | 0.85 X | ||||
| Cash Flow From Operations | (11.28 M) | ||||
| Earnings Per Share | (0.81) X | ||||
| Market Capitalization | 23.81 M | ||||
| Total Asset | 27.76 M | ||||
| Retained Earnings | (108.38 M) | ||||
| Working Capital | 20.12 M | ||||
About Femasys Performance
Evaluating Femasys' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Femasys has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Femasys has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 640.67 | 672.70 | |
| Return On Tangible Assets | (0.51) | (0.54) | |
| Return On Capital Employed | (0.59) | (0.62) | |
| Return On Assets | (0.51) | (0.54) | |
| Return On Equity | (0.78) | (0.74) |
Things to note about Femasys performance evaluation
Checking the ongoing alerts about Femasys for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Femasys help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Femasys generated a negative expected return over the last 90 days | |
| Femasys has some characteristics of a very speculative penny stock | |
| Femasys has high historical volatility and very poor performance | |
| Femasys has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.07 M. Net Loss for the year was (14.25 M) with profit before overhead, payroll, taxes, and interest of 764.28 K. | |
| Femasys currently holds about 19.12 M in cash with (11.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Femasys has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed Infertility Treatment |
- Analyzing Femasys' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Femasys' stock is overvalued or undervalued compared to its peers.
- Examining Femasys' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Femasys' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Femasys' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Femasys' stock. These opinions can provide insight into Femasys' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Femasys Stock Analysis
When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.